| Filed On | Filing |
|---|---|
| 09 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of November 6, 2026, by and among iSpecimen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its ... |
| 05 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +3 more
THIS AMENDMENT AGREEMENT (this “Amendment”) is dated for reference October 1, 2026 between Foldlab AI Ltd. (“Seller”) and iSpecimen Inc. (“Buyer”). Seller and Buyer are referred to together as the “Parties” and individually as a “Party”. |
| 02 Nov 2026 |
8-K: Submission of Matters to a Vote of Security Holders
As previously reported, on October 9, 2026, iSpecimen Inc. (the “Company”) convened a special meeting of stockholders (the “Special Meeting”), at which the Company’s stockholders voted on Proposal Nos. 1, 3, 4 and 5, and the Special Meet... |
| 09 Oct 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On October 9, 2026, iSpecimen Inc. (the “Company”) held a special meeting of stockholders (the “Special Meeting”). As of the close of business on August 12, 2026, the record date for the Special Meeting, there were 2,518,590 shares of th... |
| 10 Sep 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On September 8, 2026, iSpecimen Inc. (the “Company”) received a letter dated September 8, 2026 (the “Deficiency Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it h... |
| 04 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is made as of [*], 2026 (the “Execution Date”) between Foldlab AI Ltd., a company duly organized and existing under the laws of British Columbia (“Seller”), and iSpecimen Inc., a Delaware ... |
| 31 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
This Independent Contractor Agreement (the “Agreement”) is made and entered into as of this August 26, 2026 by and between iSpecimen Inc., a Delaware corporation, and Shahin Behroyan Lim (the “Contractor”) through his personal corporatio... |
| 14 Aug 2026 |
8-K: Entry into a Material Definitive Agreement
IR Agency LLC (the “Consultant” or “IR Agency”) is pleased to provide certain consulting services to Ispecimen (ISPC) (“you,” “Client” or “Company”) as more fully described in this agreement (the “Agreement”). This Agreement sets forth t... |
| 11 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
This Settlement Agreement and Mutual Release (the “Agreement”) is entered into by and between WestPark Capital, Inc. (“WestPark”) and iSpecimen, Inc. (“iSpecimen”). WestPark and iSpecimen are referred to individually as a “Party” and col... |
| 07 Aug 2026 |
8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure
This Securities Purchase Agreement (this “Agreement”) is dated as of [*], 2026, between iSpecimen Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors a... |
| 14 Jul 2026 |
8-K: Other Events
On July 9, 2026, iSpecimen Inc. (the “Company”) completed Milestone 3 in the Company’s digital transformation program powered by SalesStack Solutions. Pursuant to Section 3.1 of the Definitive Software Purchase and Services Agreement bet... |
| 01 Jun 2026 |
8-K: Notice of Delisting or Failure to Satisfy a Listing Rule
On May 29, 2026, iSpecimen Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it no longer complies with Nasdaq Listing Ru... |
| 29 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
At the reconvened 2025 Annual Meeting of Stockholders (the “Annual Meeting”) of iSpecimen Inc. (the “Company”) on May 29, 2026, of the Company’s 8,478,579 shares of common stock issued and outstanding and eligible to vote as of the recor... |
| 13 May 2026 |
8-K: Entry into a Material Definitive Agreement; Notice of Delisting or Failure to Satisfy a Listing Rule +3 more
This Securities Purchase Agreement (this “Agreement”) is entered into and made effective as of [_______], 2026, by and among iSpecimen Inc., a Delaware corporation (the “Company”), each purchaser identified on the signature pages hereto ... |
| 01 May 2026 |
8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Other Events
iSpecimen Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY CERTIFY AS FOLLOWS: |
| 13 Apr 2026 |
8-K: Other Events
On December 31, 2025, iSpecimen Inc. (the “Company”) convened its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Because a quorum was not present, the Company adjourned the Annual Meeting to permit additional time for stockh... |
| 10 Apr 2026 |
8-K: Regulation FD Disclosure
Woburn, MA — April 9, 2026 — iSpecimen, an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and inter... |
| 13 Mar 2026 |
8-K: Other Events
On December 31, 2025, iSpecimen Inc. (the “Company”) convened its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Because a quorum was not present, the Company adjourned the Annual Meeting to permit additional time for stockh... |
| 23 Feb 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On February 17, 2026, Ms. Siyun Yang resigned as a director of iSpecimen Inc. (the “Company”), effective immediately. Ms. Yang’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s ... |
| 18 Feb 2026 |
8-K: Other Events
On December 31, 2025, iSpecimen Inc. (the “Company”) convened its 2025 Annual Meeting of Stockholders (the “Annual Meeting”). Because a quorum was not present, the Company adjourned the Annual Meeting to permit additional time for stockh... |
Loading...